CFTR and cystic fibrosis: The introduction of the Cystic Fibrosis Transmembrane Conductance Regular (CFTR) modulator, a triple combination of elexacaftor, tezacaftor, and ivacaftor (ETI, TRIKAFTA®), has led to substantial improvements in lung function for people with cystic fibrosis (pwCF) [1].